All Viruses articles – Page 25
-
NewsUnravelling the complex role of climate in dengue dynamics
A research recently shows that specific climates of the region could greatly influence the change in disease dynamics of dengue fever and other climate-related infectious diseases, through analyzing the casual relationships between both.
-
NewsReemergence of dengue serotype 3 may increase severity of outbreaks of the disease in Brazil
From the genomic and epidemiological surveillance of the circulating dengue virus strains, a more severe dengue epidemic may occur in Brazil, due to the re-establishment of dengue virus serotype 3 (DENV-3) and persists alongside with the serotype 1 and 2 (DENV-1 and DENV-2).
-
NewsNew study sheds light on the causes of fevers of unknown origin in sub-Saharan Africa
By conducting a retrospective observational study, the causes of fevers of unknown origin (FUO) in sub-Saharan Africa were investigated using conventional diagnostic methods, highlighting the appropriate needs of point-of-care testing in the regions.
-
NewsBiosensing platform simultaneously detects vitamin C and SARS-CoV-2
A portable and sensitive biosensing device has been developed by engineering researchers to detect both SAR-CoV-2 and vitamin C simultaneously, to monitor and boost health for the general public.
-
NewsUncovering two rare infectious diseases which might be responsible for COVID-19
A study has adopted a more-advanced AI technique that revealed two rare infectious diseases might be involved in causing the emergence of COVID-19. The machine learning technique is also important to be used for other biomarker studies.
-
NewsInfluenza A viruses adapt shape in response to environmental pressures
Influenza A virus particles strategically adapt their shape—to become either spheres or larger filaments—to favor their ability to infect cells depending on environmental conditions, according to a new study.
-
NewsFrom Spanish flu to today: how immune cells keep up with a changing virus
In a breakthrough for influenza research, scientists have discovered immune cells that can recognise influenza (flu) viruses even as they mutate, raising hopes for a longer-lasting vaccine and a universal protection against future flu pandemics.
-
NewsBreakthroughs in TB vaccine and drug development pave way for global health advancements
An international team of researchers unveils groundbreaking progress in TB vaccine development and therapeutic innovations, offering hope to curb the disease’s devastating impact.
-
NewsWhy some kids get sicker: The hidden power of nose bacteria
A scoping review unravels how bacterial colonization in the respiratory tract impacts both the severity of respiratory syncytial virus (RSV) infections and long-term respiratory health in children.
-
NewsBat genome signposts new potential pathway to fight viruses with genomic characterization
A promising discovery has been made from a study that deciphers how bats are more resistant to viral infections than human using genome annotations of transposable elements in bats to pave a way for adapting the bats’ immunity against future viral outbreaks.
-
NewsJumbo phages deploying secret handshakes could usher in new antibiotics
Jumbo phages create a restricted space inside bacteria where they can copy their DNA while surrounded by a protective shield. A new study reveals that the shield works via a set of ’secret handshakes’, allowing only a specific set of useful proteins to pass through.
-
NewsFirst success in overcoming gene therapy challenges deploys nanomachines loaded with wine ingredients
Scientists have demonstrated the ability to overcome significant challenges in gene therapy using adeno-associated virus vectors (AAV) by employing a novel smart nanomachine equipped with AAV.
-
NewsStudy shows some species are susceptible to broad range of viruses
A study of fruit flies shows some species are highly susceptible to a wide range of viruses. But fly species that were resistant to one virus were generally resistant to others – including very different types of virus.
-
NewsNasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19 is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA).
-
NewsNew study reveals how Sudan virus binds to human cells
The interaction between human NPC1 receptor and Sudan virus, closely related to Ebola virus, has been structurally characterised, and gives insight to the pathogenesis of other related filoviruses.
-
NewsNew phage platform pinpoints viruses that can deliver a knockout blow for killer bacteria
An international group of microbial experts has launched a powerful and flexible free online genomic toolkit for more rapid development of phage therapy. They say it is capable of assessing if a phage is suitable for a targeted therapy in under 10 minutes.
-
NewsNIH awards $20.6 million grant to establish Human Virome Characterization Center at UCLA
NIH has awarded a $20.6 million grant over five years to establish one of five Human Virome Characterization Centers to advance understanding of the virome’s role in human health and disease across the oral-gut-brain axis.
-
NewsHow worried should we be about bird flu? An expert explains.
As U.S. health officials announce that a new strain of avian flu, H5N9, has been discovered on a duck farm in California, UC Berkeley School of Public Health’s John Swartzberg opens up on how much of a threat it poses.
-
NewsVirus that causes COVID-19 increases risk of cardiac events
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular events.
-
NewsStudy uncovers how dengue virus hijacks human plasmin for infection
Scientists characterized and revealed the correct structural bindings between dengue virus and human plasmin from mosquito blood meal to allow better understanding in dengue virus pathogenesis.